COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 1423: Articles 14221-14230  | Next

Infection fatality rate of COVID-19 in community-dwelling populations with emphasis on the elderly: An overview
Axfors, C., Ioannidis, J. P. A.
10.1101/2021.07.08.21260210 — Posted: 2021-07-13 Discussion: Onsite | Offsite
Humoral immune response in inactivated SARS-CoV-2 vaccine: When should a booster dose be administered?
Kara, E., Tanir, F., Demirhindi, H., Mete, B., Kibar, F., Cetiner, S., Candevir, A., Inaltekin, A.
10.1101/2021.07.08.21260194 — Posted: 2021-07-13
Drug-free nasal spray as a barrier against SARS-CoV-2 infection: safety and efficacy in human nasal airway epithelia
Fais, F., Juskeviciene, R., Francardo, V., Mateos, S., Constant, S., Borelli, M., Hohenfeld, I. P., Meyer, T.
10.1101/2021.07.12.452021 — Posted: 2021-07-12
Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
O'Donnell, K. L., Pinski, A. N., Clancy, C. S., Gourdine, T., Shifflett, K., Fletcher, P., Messaoudi, I., Marzi, A.
10.1101/2021.07.11.451964 — Posted: 2021-07-12
Daily sampling of early SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness
Ke, R., Martinez, P. P., Smith, R. L., Gibson, L. L., Mirza, A., Conte, M., Gallagher, N., Luo, C. H., Jarrett, J., Conte, A., Liu, T., Farjo, M., Walden, K. K. O., Rendon, G., Fields, C. J., Wang, L., Fredrickson, R., Edmonson, D. C., Baughman, M. E., Chiu, K. K., Choi, H., Scardina, K. R., Bradley, S., Gloss, S. L., Reinhart, C., Yedetore, J., Quicksall, J., Owens, A. N., Broach, J., Barton, B., Lazar, P., Heetderks, W., Robinson, M. L., Mostafa, H. H., Manabe, Y. C., Pekosz, A., McManus, D. D., Brooke, C. B.
10.1101/2021.07.12.21260208 — Posted: 2021-07-12
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: a Computational Model of Epitope Loss in Variants of Concern
Triveri, A., Serapian, S. A., Marchetti, F., Doria, F., Pavoni, S., Cinquini, F., Moroni, E., Rasola, A., Frigerio, F., Colombo, G.
10.1101/2021.07.12.452002 — Posted: 2021-07-12
High rate of mutational events in SARS-CoV-2 genomes across Brazilian geographical regions, February 2020 to June 2021
Souza, U. J. B. d., Santos, R. N. d., Campos, F. S., Lourenco, K. L., Fonseca, F. G. d., Spilki, F. R., Corona-omica.BR MCTI Network
10.1101/2021.07.10.451922 — Posted: 2021-07-12 Discussion: Onsite
Niclosamide reverses SARS-CoV-2 control of lipophagy
Garrett, T., Coatsworth, H., Mahmud, I., Hamerly, T., Stephenson, C. J., Yazd, H., Ayers, J. B., Miller, M., Lednicky, J. A., Dinglasan, R. R.
10.1101/2021.07.11.451951 — Posted: 2021-07-12
Viral infection and Transmission in a large well-traced outbreak caused by the Delta SARS-CoV-2 variant
Li, B., Deng, A., Li, K., Hu, Y., Li, Z., Xiong, Q., Liu, Z., Guo, Q., Zou, L., Zhang, H., Zhang, M., Ouyang, F., Su, J., Su, W., Xu, J., Lin, H., Sun, J., Peng, J., Jiang, H., Zhou, P., Hu, T., Luo, M., Zhang, Y., Zheng, H., Xiao, J., Liu, T., Che, R., Zeng, H., Zheng, Z., Huang, Y., Yu, J., Yi, L., Wu, J., Chen, J., Zhong, H., Deng, X., Kang, m., Pybus, O. G., Hall, M., Lythgoe, K. A., Li, Y., Yuan, J., He, J., Lu, J.
10.1101/2021.07.07.21260122 — Posted: 2021-07-12 Discussion: Onsite | Offsite
Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines
Albalawi, O. M., Alomran, M. I., Alsagri, G. M., Althunian, T. A., Alshammari, T. M.
10.1101/2021.07.10.21260304 — Posted: 2021-07-12 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).